Viewing Study NCT02530060


Ignite Creation Date: 2025-12-25 @ 2:01 AM
Ignite Modification Date: 2026-02-12 @ 9:15 AM
Study NCT ID: NCT02530060
Status: COMPLETED
Last Update Posted: 2017-01-02
First Post: 2015-08-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Pharmacokinetics of Rilpivirine/Tenofovir/Emtricitabine After a Single-Oral Administration in Healthy Japanese Adult Male Participants
Sponsor: Janssen Pharmaceutical K.K.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module